| Compound | Mode | Product name | Product code |
|---|---|---|---|
| Antibody drug conjugate (Cysteine-conjugated ADC mimic) | Reversed phase | YMC-Triart Bio C4 | TB30SP9-05Q1WT |
| Antibody drug conjugate (site-specific ADC) | Reversed phase | YMC-Triart Bio C4 | TB30S03-1546WT |
| Drug-to-Antibody Ratio (DAR) analysis of ADCs | Hydrophobic interaction | BioPro HIC HT | BHH00SQ3-1046WT |
| Antibody-Drug Conjugates (Brentuximab vedotin) | Size exclusion | YMC-SEC MAB | DLM25S03-3046WT |
| Antibody-Drug Conjugates (Brentuximab vedotin) | Ion exchange | Accura BioPro IEX SF | SF00S03-1046PTC |
| Ion exchange | Accura BioPro IEX SF | SF00S03-10Q1PTC |
